Advances in Immuno-Oncology USA Congress
October 11 - 12, 2018 - San Diego UKOxford Global Conferences
d.dalby@oxfordglobal.co.uk
Phone:+44 (0)1865 248 455
Join Oxford Global for the inaugural Advances in Immuno-Oncology USA Congress on the 11th – 12th October 2018 in San Diego, USA. There will be over 350 delegates representing global pharmaceutical organisations, leading biotech companies, and internationally renowned academic institutions. View Agenda: https://bit.ly/2vrwiwW Hear from leading experts within the immuno-oncology field through over 20 presentations, case studies and panel discussions focuser on the latest innovations in Car-T cell development, patient stratification, and assay developments in the immuno-oncology world. 2 Interactive Streams: • Development of Immuno-Oncology Therapies – Stream 1 features presentations on the latest developments in T Cell Engagers, cell based functional assays for IDO inhibitors, harnessing novel immune escape mechanisms for cancer therapeutics and toxicities with immuno-oncology therapy • Translational Immuno-Oncology and Clinical Based Development – Stream 2 addresses talks on the latest patient stratification innovations in immuno-oncology, identifying immunological biomarkers for precision cancer immunotherapy and biomarker based selections in clinical trials. Register for our live, pre-congress webinar for free today: https://bit.ly/2IrjJXR The Role for TNFR2 in the Tumor Microenvironment Thursday 14th June 2018, 4pm BST Presented by Russell LaMontagne, Chief Executive Officer: Boston Immune Technologies and Therapeutics Inc For further information regarding prices and possible discounts, please contact Danielle Dalby on d.dalby@oxfordglobal.co.uk or call +44 (0)1865 248 455.